Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
暂无分享,去创建一个
I. Christensen | H. Poulsen | U. Lassen | H. Broholm | T. Urup | L. Gillberg | S. Michaelsen | K. Grønbaek | K. Kaastrup | M. Lü | Vibeke Andrée Larsen